vs

Side-by-side financial comparison of ROCKY BRANDS, INC. (RCKY) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

ROCKY BRANDS, INC. is the larger business by last-quarter revenue ($139.7M vs $127.1M, roughly 1.1× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 9.1%). ROCKY BRANDS, INC. produced more free cash flow last quarter ($16.7M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 11.2%).

Rocky Brands, Inc., formerly known as Rocky Shoes & Boots, Inc., is a company which designs, develops, manufactures, and markets outdoor, work, western and military footwear, and other outdoor and work apparel and accessories. The company was founded in 1932 in Nelsonville, Ohio, and still maintains its corporate headquarters there.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

RCKY vs ZLAB — Head-to-Head

Bigger by revenue
RCKY
RCKY
1.1× larger
RCKY
$139.7M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+8.0% gap
ZLAB
17.1%
9.1%
RCKY
More free cash flow
RCKY
RCKY
$43.4M more FCF
RCKY
$16.7M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
11.2%
RCKY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RCKY
RCKY
ZLAB
ZLAB
Revenue
$139.7M
$127.1M
Net Profit
$6.5M
Gross Margin
41.3%
51.0%
Operating Margin
6.9%
-54.6%
Net Margin
4.7%
Revenue YoY
9.1%
17.1%
Net Profit YoY
35.7%
EPS (diluted)
$0.86
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RCKY
RCKY
ZLAB
ZLAB
Q4 25
$139.7M
$127.1M
Q3 25
$122.5M
$115.4M
Q2 25
$105.6M
$109.1M
Q1 25
$114.1M
$105.7M
Q4 24
$128.1M
$108.5M
Q3 24
$114.6M
$101.8M
Q2 24
$98.3M
$100.1M
Q1 24
$112.9M
$87.1M
Net Profit
RCKY
RCKY
ZLAB
ZLAB
Q4 25
$6.5M
Q3 25
$7.2M
$-36.0M
Q2 25
$3.6M
$-40.7M
Q1 25
$4.9M
$-48.4M
Q4 24
$4.8M
Q3 24
$5.3M
$-41.7M
Q2 24
$-1.2M
$-80.3M
Q1 24
$2.5M
$-53.5M
Gross Margin
RCKY
RCKY
ZLAB
ZLAB
Q4 25
41.3%
51.0%
Q3 25
40.2%
59.5%
Q2 25
41.0%
60.6%
Q1 25
41.2%
63.6%
Q4 24
41.5%
61.5%
Q3 24
38.1%
64.1%
Q2 24
38.7%
64.9%
Q1 24
39.1%
61.4%
Operating Margin
RCKY
RCKY
ZLAB
ZLAB
Q4 25
6.9%
-54.6%
Q3 25
9.6%
-42.3%
Q2 25
6.8%
-50.3%
Q1 25
7.6%
-53.3%
Q4 24
6.6%
-62.6%
Q3 24
8.8%
-66.6%
Q2 24
4.6%
-76.0%
Q1 24
7.1%
-80.7%
Net Margin
RCKY
RCKY
ZLAB
ZLAB
Q4 25
4.7%
Q3 25
5.9%
-31.2%
Q2 25
3.4%
-37.3%
Q1 25
4.3%
-45.8%
Q4 24
3.7%
Q3 24
4.6%
-40.9%
Q2 24
-1.3%
-80.2%
Q1 24
2.3%
-61.4%
EPS (diluted)
RCKY
RCKY
ZLAB
ZLAB
Q4 25
$0.86
$-0.05
Q3 25
$0.96
$-0.03
Q2 25
$0.48
$-0.04
Q1 25
$0.66
$-0.04
Q4 24
$0.65
$-0.09
Q3 24
$0.70
$-0.04
Q2 24
$-0.17
$-0.08
Q1 24
$0.34
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RCKY
RCKY
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$2.9M
$689.6M
Total DebtLower is stronger
$122.6M
Stockholders' EquityBook value
$252.1M
$715.5M
Total Assets
$477.5M
$1.2B
Debt / EquityLower = less leverage
0.49×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RCKY
RCKY
ZLAB
ZLAB
Q4 25
$2.9M
$689.6M
Q3 25
$3.3M
$717.2M
Q2 25
$2.8M
$732.2M
Q1 25
$2.6M
$757.3M
Q4 24
$3.7M
$779.7M
Q3 24
$3.7M
$616.1M
Q2 24
$4.1M
$630.0M
Q1 24
$3.1M
$650.8M
Total Debt
RCKY
RCKY
ZLAB
ZLAB
Q4 25
$122.6M
Q3 25
$139.0M
Q2 25
$132.5M
Q1 25
$128.6M
Q4 24
$128.7M
Q3 24
$150.3M
Q2 24
$152.4M
Q1 24
$156.0M
Stockholders' Equity
RCKY
RCKY
ZLAB
ZLAB
Q4 25
$252.1M
$715.5M
Q3 25
$246.1M
$759.9M
Q2 25
$239.1M
$791.7M
Q1 25
$236.2M
$810.8M
Q4 24
$232.2M
$840.9M
Q3 24
$228.3M
$667.7M
Q2 24
$223.8M
$704.2M
Q1 24
$225.3M
$762.2M
Total Assets
RCKY
RCKY
ZLAB
ZLAB
Q4 25
$477.5M
$1.2B
Q3 25
$494.0M
$1.2B
Q2 25
$471.0M
$1.2B
Q1 25
$468.2M
$1.2B
Q4 24
$457.3M
$1.2B
Q3 24
$475.0M
$985.3M
Q2 24
$467.9M
$987.4M
Q1 24
$466.5M
$988.4M
Debt / Equity
RCKY
RCKY
ZLAB
ZLAB
Q4 25
0.49×
Q3 25
0.57×
Q2 25
0.55×
Q1 25
0.54×
Q4 24
0.55×
Q3 24
0.66×
Q2 24
0.68×
Q1 24
0.69×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RCKY
RCKY
ZLAB
ZLAB
Operating Cash FlowLast quarter
$17.6M
$-26.0M
Free Cash FlowOCF − Capex
$16.7M
$-26.7M
FCF MarginFCF / Revenue
12.0%
-21.0%
Capex IntensityCapex / Revenue
0.6%
0.5%
Cash ConversionOCF / Net Profit
2.70×
TTM Free Cash FlowTrailing 4 quarters
$9.7M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RCKY
RCKY
ZLAB
ZLAB
Q4 25
$17.6M
$-26.0M
Q3 25
$-3.3M
$-32.0M
Q2 25
$812.0K
$-31.0M
Q1 25
$1.2M
$-61.7M
Q4 24
$24.4M
$-55.8M
Q3 24
$4.5M
$-26.8M
Q2 24
$6.5M
$-42.2M
Q1 24
$17.4M
$-90.1M
Free Cash Flow
RCKY
RCKY
ZLAB
ZLAB
Q4 25
$16.7M
$-26.7M
Q3 25
$-5.2M
$-35.0M
Q2 25
$-2.4M
$-33.9M
Q1 25
$529.0K
$-63.2M
Q4 24
$22.9M
$-58.4M
Q3 24
$3.5M
$-28.2M
Q2 24
$4.6M
$-42.9M
Q1 24
$17.1M
$-91.1M
FCF Margin
RCKY
RCKY
ZLAB
ZLAB
Q4 25
12.0%
-21.0%
Q3 25
-4.2%
-30.4%
Q2 25
-2.2%
-31.1%
Q1 25
0.5%
-59.9%
Q4 24
17.9%
-53.8%
Q3 24
3.0%
-27.7%
Q2 24
4.7%
-42.9%
Q1 24
15.2%
-104.5%
Capex Intensity
RCKY
RCKY
ZLAB
ZLAB
Q4 25
0.6%
0.5%
Q3 25
1.5%
2.6%
Q2 25
3.0%
2.6%
Q1 25
0.6%
1.5%
Q4 24
1.2%
2.4%
Q3 24
0.9%
1.3%
Q2 24
1.9%
0.7%
Q1 24
0.2%
1.1%
Cash Conversion
RCKY
RCKY
ZLAB
ZLAB
Q4 25
2.70×
Q3 25
-0.46×
Q2 25
0.23×
Q1 25
0.25×
Q4 24
5.08×
Q3 24
0.85×
Q2 24
Q1 24
6.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RCKY
RCKY

Wholesale$79.6M57%
Retail1$57.0M41%
Contract Manufacturing$3.2M2%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons